Portugal - Produtos farmacêuticos - C/ BASE NO CPA 2025_1589 - AMIVANTAMAB 1600 MG/10 ML+AMIVANTAMAB 2240 MG

different companies won its awards

631

of the awards went to the three most frequent winners

5%

of its calls state an estimated value

100%

Based on 1,780 awards with a named winner over the last 3 years. Counted by award, not by value, because lot and framework amounts are not comparable. Concentrated means the three most frequent winners took 65% or more of the awards; many suppliers, under 35% with at least ten different winners.

Competition

tenders per lot on average (open and restricted procedures)

1.7

of those lots received a single tender

67%

of the awards went to companies based in another country

5%

As the official award notices state them, over the last 3 years. Tenders per lot count open and restricted procedures only: in a negotiated procedure or a direct award a single tender is the procedure itself. The country is the one the notice gives for the winner.

Portugal · Medical equipment & pharmaceuticals

different companies won awards here

2,015

of the awards went to the three most frequent winners

6%

buyers awarded contracts here

454

Based on 23,210 awards with a named winner over the last 3 years. Counted by award, not by value, because lot and framework amounts are not comparable. Concentrated means the three most frequent winners took 65% or more of the awards; many suppliers, under 35% with at least ten different winners.

Competition

tenders per lot on average (open and restricted procedures)

4.0

of those lots received a single tender

59%

of the awards went to companies based in another country

1%

of the tenders came from another country

3%

As the official award notices state them, over the last 3 years. Tenders per lot count open and restricted procedures only: in a negotiated procedure or a direct award a single tender is the procedure itself. The country is the one the notice gives for the winner.